Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure

Proteomics

Volumn 13, Issue 15, 2013, Pages 2324-2334

  Chugh, Shaan ^a,b   Ouzounian, Maral ^b,c   Lu, Zhen ^a,b   Mohamed, Shanas ^b,c   Li, Wenping ^a,b   Bousette, Nicolas ^a,b,e   Liu, Peter P ^b,c,d   Gramolini, Anthony O ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Animal proteomics; Bioinformatics; Plasma; Secreted protein

Indexed keywords

BIOLOGICAL MARKER; CROSS REACTING ANTIBODY; DESMIN; LIPOCORTIN 2; MYOSIN HEAVY CHAIN; PROTEOME; SOMATOMEDIN;

ARTICLE; EXPLANT; FILTRATION; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PILOT STUDY; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINE;

EID: 84881222874     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200455     Document Type: Article

References (49)

1. Jong, P., Gong, Y., Liu, P. P., Austin, P. C. et al., Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation 2003, 108, 184-191.
2. Jong, P., Vowinckel, E., Liu, P. P., Gong, Y., Tu, J. V., Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch. Intern. Med. 2002, 162, 1689-1694.
3. Arnold, J. M., Liu, P., Demers, C., Dorian, P. et al., Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can. J. Cardiol. 2006, 22, 23-45.
4. Lee, D. S., Mamdani, M. M., Austin, P. C., Gong, Y. et al., Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am. J. Med. 2004, 116, 581-589.
5. Ross, H., Howlett, J., Arnold, J. M., Liu, P. et al., Treating the right patient at the right time: access to heart failure care. Can. J. Cardiol. 2006, 22, 749-754.
6. Yan, A. T., Yan, R. T., Liu, P. P., Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials. Ann. Intern. Med. 2005, 142, 132-145.
7. Doust, J. A., Glasziou, P. P., Pietrzak, E., Dobson, A. J., A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch. Intern. Med. 2004, 164, 1978-1984.
8. Doust, J., Lehman, R., Glasziou, P., The role of BNP testing in heart failure. Am. Fam. Physician 2006, 74, 1893-1898.
9. Cameron, S. J., Green, G. B., Cardiac biomarkers in renal disease: the fog is slowly lifting. Clin. Chem. 2004, 50, 2233-2235.
10. Arnold, J. M., Howlett, J. G., Dorian, P., Ducharme, A. et al., Canadian CardiovascularSociety Consensus Conference recommendations on heart failure update 2007: prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can. J. Cardiol. 2007, 23, 21-45.
11. Maisel, A., Mueller, C., Adams, K., Jr., Anker, S. D. et al., State of the art: using natriuretic peptide levels in clinical practice. Eur J. Heart Fail. 2008, 10, 824-839.
12. Molkentin, J. D., Lu, J. R., Antos, C. L., Markham, B. et al, A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93, 215-228.
13. Gramolini, A. O., Kislinger, T., Alikhani-Koopaei, R., Fong, V., et al., Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol. Cell. Proteomics 2008, 7, 519-533.
14. Donahue, M. P., Rose, K., Hochstrasser, D., Vonderscher, J. et al. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am. Heart J. 2006, 152, 478-485.
15. Barallobre-Barreiro, J., Didangelos, A., Schoendube, F. A., Drozdov, I. et al., Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 2012, 125, 789-802.
16. Bousette, N., Chugh, S., Fong, V., Isserlin, R. et al., Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by α-crystallin-B. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 18481-18486.
17. Kislinger, T., Cox, B., Kannan, A., Chung, C. et al., Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006, 125, 173-186.
18. Yates, J. R., 3rd, Eng, J. K., McCormack, A. L., Schieltz, D., Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 1995, 67, 1426-1436.
19. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
20. States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D. et al., Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 2006, 24, 333-338.
21. Galindo, C. L., Skinner, M. A., Errami, M., Olson, L. D. et al., Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiol. 2009, 9, 23.
22. Mirotsou, M., Dzau, V. J., Pratt, R. E., Weinberg, E. O., Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. Physiol. Genomics 2006, 27, 86-94.
23. Rajan, S., Williams, S. S., Jagatheesan, G., Ahmed, R. P. et al., Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy. Physiol. Genomics 2006, 27, 309-317.
24. Kampf, C., Bergman, J., Oksvold, P., Asplund, A. et al., A tool to facilitate clinical biomarker studies-a tissue dictionary based on the Human Protein Atlas. BMC Med. 2012, 10, 103.
25. Ponten, F., Jirstrom, K., Uhlen, M., The Human Protein Atlas-a tool for pathology. J. Pathol. 2008, 216, 387-393.
26. Uhlen, M., Bjorling, E., Agaton, C., Szigyarto, C. A. et al., A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell. Proteomics 2005, 4, 1920-1932.
27. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E. et al., Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28, 1248-1250.
28. Uhlen, M., Ponten, F., Antibody-based proteomics for human tissue profiling. Mol. Cell. Proteomics 2005, 4, 384-393.
29. Thom, T., Haase, N., Rosamond, W., Howard, V. J. et al., Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113, e85-151.
30. Ahmad, T., Fiuzat, M., Felker, G. M., O'Connor, C., Novel biomarkers in chronic heart failure. Nat. Rev. Cardiol. 2012, 9, 347-359.
31. Azuaje, F. J., Dewey, F. E., Brutsaert, D. L., Devaux, Y. et al., Systems-based approaches to cardiovascular biomarker discovery. Circ. Cardiovasc. Genet. 2012, 5, 360-367.
32. Kesidis, N., Metaxas, T. I., Vrabas, I. S., Stefanidis, P. et al., Myosin heavy chain isoform distribution in single fibres of bodybuilders. Eur. J. Appl. Physiol. 2008, 103, 579-583.
33. Wang, T. J., Significance of circulating troponins in heart failure: if these walls could talk. Circulation 2007, 116, 1217-1220.
34. Horwich, T. B., Patel, J., MacLellan, W. R., Fonarow, G. C., Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108, 833-838.
35. Wu, A. H., Ford, L., Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin. Chim. Acta 1999, 284, 161-174.
36. Wen, J. J., Zago, M. P., Nunez, S., Gupta, S. et al., Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease. Mol. Cell. Proteomics 2012, 11, 435-452.
37. Lam, L., Tsoutsman, T., Arthur, J., Semsarian, C., Differential protein expression profiling of myocardial tissue in a mouse model of hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 2009, 48, 1014-1022.
38. Pawlak, A., Gil, R. J., Kulawik, T., Pronicki, M. et al., Type of desmin expression in cardiomyocytes-a good marker of heart failure development in idiopathic dilated cardiomyopathy. J. Int. Med. 2012, 272, 287-297.
39. Scholz, D., Diener, W., Schaper, J., Altered nucleus/cytoplasm relationship and degenerative structural changes in human dilated cardiomyopathy. Cardioscience 1994, 5, 127-138.
40. Mirza, M., Marston, S., Willott, R., Ashley, C. et al., Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J. Biol. Chem. 2005, 280, 28498-28506.
41. Hayes, M. J., Longbottom, R. E., Evans, M. A., Moss, S. E., Annexinopathies. Subcell. Biochem. 2007, 45, 1-28.
42. Hwang, J. J., Allen, P. D., Tseng, G. C., Lam, C. W. et al., Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol. Genomics 2002, 10, 31-44.
43. Benevolensky, D., Belikova, Y., Mohammadzadeh, R., Trouve, P. et al., Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure. Lab. Invest. 2000, 80, 123-133.
44. Kim, H. S., Nagalla, S. R., Oh, Y., Wilson, E. et al., Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Natl. Acad. Sci. U.S.A 1997, 94, 12981-12986.
45. Neuvians, T. P., Gashaw, I., Hasenfus, A., Hacherhacker, A. et al., Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue. Neoplasia 2005, 7, 446-456.
46. Dinh, W., Barroso, M. C., Futh, R., Lankisch, M. et al., Serum insulin like growth factor-I and its binding protein-7: novel promising biomarker in heart failure with preserved ejection fraction. Clin. Res. Cardiol. 2012, 101, P1288.
47. Flaherty, J. D., Bax, J. J., De Luca, L., Rossi, J. S. et al., Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J. Am. Coll. Cardiol. 2009, 53, 254-263.
48. Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C. et al., Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med. 2006, 355, 260-269.
49. Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J. et al., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 2006, 355, 251-259.